Results were comparable to 82 benchmark patients , with similar low rates of major hypoglycaemia ( 2/89 vs. 0/82 ; p = 0.17 ) and less loss to follow up in the INITIATION group ( 3/92 vs. 14/82 ; p = 0.002 ) .